FTC: Surescripts case not moot even if conduct stopped

The Federal Trade Commission says it should be allowed to keep litigating claims that Surescripts illegally monopolised markets for e-prescription services despite the company claiming to have removed the contractual terms at issue.

Unlock unlimited access to all Global Competition Review content